Signup Crypto ETF Stocks News

Verisign exec. chairman D. James Bidzos sells $938k in common stock

D. James Bidzos, Executive Chairman, President, and CEO of VeriSign Inc. (NASDAQ:VRSN), sold 3,300 shares of the company's common stock for a total of $938,524 on September 8, 2026. The stock is currently trading at $286.91 and appears overvalued according to InvestingPro analysis, despite the company maintaining impressive gross profit margins of 88% and a 17% year-to-date return. Following these transactions, Bidzos directly holds 391,627.4109 shares.

Source: Investing.com Canada
September 09, 2026 | 21:19:14
Category: General

Verisign exec. chairman D. James Bidzos sells $938k in common stock

D. James Bidzos, Verisign's Executive Chairman, President, and CEO, sold 3,300 shares of the company's common stock for a total of $938,524 on September 8, 2026. The stock is currently considered overvalued by InvestingPro analysis, despite the company maintaining an 88% gross profit margin and a 17% year-to-date return. Following these transactions, Bidzos directly holds 391,627.4109 shares.

Source: Investing.com India
September 09, 2026 | 21:24:43
Category: General

Super Micro Computer (SMCI) Dips More Than Broader Market: What You Should Know

Super Micro Computer (SMCI) shares recently dipped 3.07%, underperforming the broader market. Despite this, the company has seen significant gains over the past year and analysts project strong earnings and revenue growth, earning it a Zacks Rank of #1 (Strong Buy). Its current valuation also suggests it may be trading at a discount compared to its industry peers.

Source: Yahoo Finance
September 09, 2026 | 21:45:27
Category: General

Why UnitedHealth Group (UNH) Dipped More Than Broader Market Today

UnitedHealth Group (UNH) stock underperformed the broader market, closing down 1.94% against the S&P 500's 0.48% loss. Despite this dip, the company is projected to report strong Q3 earnings with a 38.01% EPS increase and analysts have recently revised their estimates upwards, contributing to its Zacks Rank #1 (Strong Buy) rating. The stock's valuation also shows it trading at a discount compared to its industry average.

Source: Yahoo Finance
September 09, 2026 | 21:50:03
Category: General

Could Advanced Micro Devices (AMD)’s Partnership With Cisco Systems (CSCO) Unlock a Massive Middle East AI Opportunity?

Advanced Micro Devices (AMD), Cisco Systems (CSCO), and Humain have launched a joint AI infrastructure in Saudi Arabia, leveraging AMD's GPUs and Cisco's networking technology. This partnership aims to provide GPU-as-a-service across the Middle East, with plans for significant expansion by 2030. The article compares the investment profiles of AMD and Cisco, highlighting AMD's hyper-growth in data centers versus Cisco's strong cash flow and defensive position in networking.

Source: Yahoo Finance
September 09, 2026 | 22:07:38
Category: General

U.S. Bancorp raises quarterly dividend 3.8% to $0.54 per share

U.S. Bancorp announced a 3.8% increase in its quarterly dividend for common shares, raising it to $0.54 per share, making the annual dividend $2.16. The dividend is payable on October 15, 2026, to stockholders of record as of September 30, 2026. The board also declared regular quarterly and semi-annual dividends for various series of preferred stock, also payable on the same date.

Source: Investing.com
September 09, 2026 | 22:09:10
Category: General

Humana sues Bayer over unpaid medical liens in Roundup settlements

Humana is suing Bayer, alleging that the pharmaceutical giant failed to reimburse the insurer for medical expenses paid on behalf of Medicare Advantage members who settled Roundup claims. The lawsuit seeks double damages, focusing on the proposed $7.25 billion class settlement related to Bayer's Roundup weedkiller. Humana claims these settlements were made without the health plan being repaid for the members' medical costs.

Source: The Business Journals
September 09, 2026 | 18:47:05
Category: General

HCA Healthcare (NYSE:HCA) Trading 5.3% Higher - Should You Buy?

HCA Healthcare (NYSE:HCA) shares rose 5.3% during mid-day trading to $423.29, despite trading volume being 22% below average. The company beat quarterly earnings and revenue estimates, reporting $7.59 EPS and $20.23 billion in revenue, an 8.7% year-over-year increase, and declared a quarterly dividend of $0.78 per share. Analysts generally maintain a "Moderate Buy" rating with an average price target of $462.64, although several recent price targets have been cut.

Source: MarketBeat
September 09, 2026 | 18:48:33
Category: General

Cintas employee-partner celebrates 60 years and counting on the job

Virginia M. is celebrating 60 years of employment with Cintas, having started her career at Willis Linen Supply in 1966. She has adapted through company acquisitions and technological changes, currently serving as an on-site administrator in Phoenix, Arizona. Virginia plans to continue working due to her enjoyment of her role and colleagues.

Source: The Business Journals
September 09, 2026 | 19:19:06
Category: General

Applied Materials CEO: Growth is driven by AI compute demand

Gary Dickerson, CEO of Applied Materials, discusses the company's business outlook. He highlights that the growth of Applied Materials is primarily fueled by the increasing demand for AI compute. This indicates a strong connection between advancements in artificial intelligence and the semiconductor industry.

Source: CNBC
September 09, 2026 | 19:43:35
Category: General

© Natavest 2025 - 2026